LHR1 inhibitors (Rakta Therapeutics)

N/A

Report date: 2025/03/20 15:07:19
NME

Base Information

Drug NameLHR1 inhibitors (Rakta Therapeutics)
Drug Alias Nameleishmania heme response 1 inhibitors (Rakta Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLeishmaniasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRakta Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesRakta Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsLeishmaniasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A